首页> 外国专利> COMPOSITION FOR TREATING DIABETES, COMPRISING LONG-ACTING INSULIN ANALOGUE CONJUGATE AND LONG-ACTING INSULINOTROPIC PEPTIDE CONJUGATE

COMPOSITION FOR TREATING DIABETES, COMPRISING LONG-ACTING INSULIN ANALOGUE CONJUGATE AND LONG-ACTING INSULINOTROPIC PEPTIDE CONJUGATE

机译:用于治疗糖尿病,长效胰岛素类似物共轭物和长效胰岛素营养肽共轭物的组合物

摘要

The present invention relates to a composition for preventing or treating diabetes mellitus comprising insulin and a GLP-1/glucagon dual agonist, and a method for preventing or treating diabetes mellitus. More specifically, the present composition can inhibit the weight gain and reduce the danger of hypoglycemia due to the administration of insulin, lower the administration dose and greatly improve the compliance of drugs through a combined administration of a long-acting insulin conjugate and a long-acting GLP-1/glucagon dual agonist conjugate. In addition, the long-acting insulin conjugate and the long-acting GLP-1/glucagon dual agonist conjugate according to the present invention can improve the in vivo sustainability and stability because an insulin and a GLP-1/glucagon dual agonist are linked to the immunoglobulin Fc region via a non-peptidyl linker.
机译:本发明涉及一种用于预防或治疗糖尿病的包含胰岛素和GLP-1 /胰高血糖素双重激动剂的组合物,以及一种用于预防或治疗糖尿病的方法。更具体地,本发明的组合物可通过长效胰岛素结合物和长效胰岛素结合物的联合给药,抑制体重增加并降低由于胰岛素给药引起的低血糖的危险,降低给药剂量并大大改善药物的依从性。 GLP-1 /胰高血糖素双重激动剂偶联物。另外,由于胰岛素和GLP-1 /胰高血糖素双重激动剂与胰岛素和GLP-1 /胰高血糖素双重激动剂结合,因此本发明的长效胰岛素结合物和长效GLP-1 /胰高血糖素双重激动剂结合物可以改善体内的可持续性和稳定性。经由非肽基接头的免疫球蛋白Fc区。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号